Pieter J L De Visschere

Learn More
OBJECTIVES To compare the spectral quality of prostate magnetic resonance spectroscopic imaging (MRSI) at 1.5Tesla with endorectal coil (ER-1.5T) to MRSI at 3.0Tesla without coil (3.0T). METHODS In(More)
PURPOSE Improved outcome is reported after surgery or external beam radiation therapy (EBRT) plus androgen deprivation therapy (ADT) for patients with lymph node (LN) positive (N1) prostate cancer(More)
Current first-line standard of therapy for metastatic urothelial carcinoma is platinum-based combination chemotherapy. Pembrolizumab in phase III has demonstrated a promising overall response rate of(More)
PURPOSE To assess the ability of combined whole-prostate magnetic resonance imaging and magnetic resonance spectroscopy imaging (MRI+MRSI) to predict the presence or absence of high grade (Gleason(More)